Literature DB >> 20949394

Best practices for establishing a biobank.

Göran Hallmans1, Jimmie B Vaught.   

Abstract

A biobank may be defined as the long-term storage of biological samples for research or clinical purposes. In addition to storage facilities, a biobank may comprise a complete organization with biological samples, data, personnel, policies, and procedures for handling specimens and performing other services, such as the management of the database and the planning of scientific studies. This combination of facilities, policies, and processes may also be called a biological resource center (BRC) ( www.iarc.fr ). Research using specimens from biobanks is regulated by European Union (EU) recommendations (Recommendations on Research on Human Biological Materials. The draft recommendation on research on human biological materials was approved by CDBI at its plenary meeting on 20 October 2005) and by voluntary best practices from the U.S. National Cancer Institute (NCI) ( http://biospecimens.cancer.gov ) and other organizations. Best practices for the management of research biobanks vary according to the institution and differing international regulations and standards. However, there are many areas of agreement that have resulted in best practices that should be followed in order to establish a biobank for the custodianship of high-quality specimens and data.

Entities:  

Mesh:

Year:  2011        PMID: 20949394     DOI: 10.1007/978-1-59745-423-0_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Structural requirements of research tissue banks derived from standardized project surveillance.

Authors:  E Herpel; N Koleganova; B Schreiber; B Walter; C V Kalle; P Schirmacher
Journal:  Virchows Arch       Date:  2012-06-01       Impact factor: 4.064

Review 2.  [Maintainance of a research tissue bank. (Infra)structural and quality aspects].

Authors:  S Schmitt; K Kynast; P Schirmacher; E Herpel
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

3.  Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks.

Authors:  S Schmitt; K Kynast; P Schirmacher; E Herpel
Journal:  Virchows Arch       Date:  2015-08-14       Impact factor: 4.064

4.  Quantifying histological features of cancer biospecimens for biobanking quality assurance using automated morphometric pattern recognition image analysis algorithms.

Authors:  Joshua D Webster; Eleanor R Simpson; Aleksandra M Michalowski; Shelley B Hoover; R Mark Simpson
Journal:  J Biomol Tech       Date:  2011-09

5.  Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies.

Authors:  Emily R Holzinger; Marylyn D Ritchie
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

6.  Enhancement of Pathologist's Routine Practice: Reuse of DNA Extracted from Immunostained Formalin-fixed Paraffin-embedded (FFPE) Slides in Downstream Molecular Analysis of Cancer.

Authors:  Asmaa Al-Attas; Mourad Assidi; Jaudah Al-Maghrabi; Ashraf Dallol; Hans-Juergen Schulten; Muhammad Abu-Elmagd; Adeel Chaudhary; Adel Abuzenadah; Bruce Budowle; Abdelbaset Buhmeida; Mohammed Al-Qahtani
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

7.  Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization.

Authors:  Bih-Rong Wei; R Mark Simpson
Journal:  Clin Biochem       Date:  2013-12-18       Impact factor: 3.281

Review 8.  Brain tumor biobanking in the precision medicine era: building a high-quality resource for translational research in neuro-oncology.

Authors:  Quinn T Ostrom; Karen Devine; Jordonna Fulop; Yingli Wolinsky; Peter Liao; Lindsay Stetson; Marta Couce; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Neurooncol Pract       Date:  2016-12-30

9.  Managing incidental findings and research results in genomic research involving biobanks and archived data sets.

Authors:  Susan M Wolf; Brittney N Crock; Brian Van Ness; Frances Lawrenz; Jeffrey P Kahn; Laura M Beskow; Mildred K Cho; Michael F Christman; Robert C Green; Ralph Hall; Judy Illes; Moira Keane; Bartha M Knoppers; Barbara A Koenig; Isaac S Kohane; Bonnie Leroy; Karen J Maschke; William McGeveran; Pilar Ossorio; Lisa S Parker; Gloria M Petersen; Henry S Richardson; Joan A Scott; Sharon F Terry; Benjamin S Wilfond; Wendy A Wolf
Journal:  Genet Med       Date:  2012-04       Impact factor: 8.822

10.  Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability.

Authors:  Charlotte Welinder; Göran Jönsson; Christian Ingvar; Lotta Lundgren; Håkan Olsson; Thomas Breslin; Akos Végvári; Thomas Laurell; Melinda Rezeli; Bo Jansson; Bo Baldetorp; György Marko-Varga
Journal:  Clin Transl Med       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.